OSAKA, Japan, August 29, 2024 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.) announced that Shionogi will implement the following personnel reassignment as of October 1, 2024.
the Diagnostics Business Office, which is in the Healthcare Business Supervisory Unit, will be placed directly under the R&D Supervisory Unit in order to strengthen collaboration with the research and development organization.